Capital International Investors 13D and 13G filings for Vir Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 11:19 am Sale | 2022-02-14 | 13G | Vir Biotechnology, Inc. VIR | Capital International Investors | 5,634,019 4.300% | -5,806,552 (-50.75%) | Filing |
| 2021-02-16 2:24 pm Unchanged | 2021-02-16 | 13G | Vir Biotechnology, Inc. VIR | Capital International Investors | 11,440,571 9.000% | 0 (Unchanged) | Filing |
| 2021-02-16 1:57 pm Purchase | 2021-02-16 | 13G | Vir Biotechnology, Inc. VIR | Capital International Investors | 11,440,571 9.000% | 11,440,571 (New Position) | Filing |